Hypersensitivity reactions to beta-lactam antibiotics.

Area of Science:

• Clinical immunology
• Infectious diseases
• Pharmacology

Background:

• Approximately 10% of the population reports penicillin or beta-lactam allergy.
• Up to 90% of patients with reported beta-lactam allergy are not truly allergic.
• Misdiagnosis of beta-lactam allergy leads to unnecessary broad-spectrum antibiotic use, increasing costs and antimicrobial resistance.

Purpose of the Study:

• To evaluate the diagnostic value of penicillin allergy skin testing.
• To guide appropriate antibiotic selection for patients with a history of beta-lactam allergy.
• To reduce the overuse of broad-spectrum antibiotics and combat antimicrobial resistance.

Main Methods:

• Review of diagnostic approaches for beta-lactam allergy.
• Analysis of penicillin skin testing utility for IgE-mediated allergy.
• Discussion of management strategies for penicillin skin test-negative and -positive patients.

Main Results:

• Validated diagnostic skin testing for penicillin allergy is available and reliable.
• Penicillin skin test-negative patients can safely receive all beta-lactam antibiotics.
• Penicillin skin test-positive patients require desensitization for penicillin-class antibiotics or cautious graded challenge for other beta-lactams.

Conclusions:

• Accurate identification of beta-lactam allergy status is crucial for appropriate antibiotic prescribing.
• Penicillin allergy testing can safely de-escalate antibiotic therapy for many patients.
• Reducing beta-lactam allergy labels improves antibiotic stewardship and helps control drug-resistant bacteria.